Showing results (71-80 of 1,899) with videos related to
Sort By:
Pageof 190
Seminars in Oncology|August 1, 1995
Difluorodeoxyguanosine: cytotoxicity, metabolism, and actions on DNA synthesis in human leukemia cellsV Gandhi, S Mineishi, P Huang, et al.Cancer Chemotherapy and Pharmacology|January 1, 1996
The effect of 9-beta-D-arabinofuranosyl-2-fluoroadenine and 1-beta-D-arabinofuranosylcytosine on the cell cycle phase distribution, topoisomerase II level, mitoxantrone cytotoxicity, and DNA strand break production in K562 human leukemia cellsS Loughlin, V Gandhi, W Plunkett, et al.Journal of Personality Assessment|August 1, 1984
Locus of control in children of divorceN Kalter, D Alpern, R Spence, et al.Cancer Research|March 1, 1980
Quantitation of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate in the leukemic cells from bone marrow and peripheral blood of patients receiving 1-beta-D-arabinofuranosylcytosine therapyW Plunkett, V Hug, M J Keating, et al.Immunological Communications|January 1, 1981
The inhibitory properties of group A and B non-secretor salivaJ F Mohn, N A Owens, R W PlunkettCancer Research|February 15, 1992
Fludarabine infusion potentiates arabinosylcytosine metabolism in lymphocytes of patients with chronic lymphocytic leukemiaV Gandhi, A Kemena, M J Keating, et al.Leukemia|September 1, 1994
Effect of granulocyte-macrophage colony-stimulating factor on the metabolism of arabinosylcytosine triphosphate in blasts during therapy of patients with chronic myelogenous leukemiaV Gandhi, M Du, H M Kantarjian, et al.Cancer Research|April 1, 1995
Cytotoxicity, metabolism, and mechanisms of action of 2',2'-difluorodeoxyguanosine in Chinese hamster ovary cellsV Gandhi, S Mineishi, P Huang, et al.Blood|November 1, 1989
Modulation of arabinosylcytosine metabolism by arabinosyl-2-fluoroadenine in lymphocytes from patients with chronic lymphocytic leukemia: implications for combination therapyV Gandhi, B Nowak, M J Keating, et al.Leukemia & Lymphoma|January 1, 1993
Biochemical modulation of arabinosylcytosine for therapy of leukemiasV Gandhi, E Estey, M J Keating, et al.Pageof 190